Stock CVM CEL-SCI CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News CEL-SCI Corporation

Equities

CVM

US1508376076

Real-time Estimate Cboe BZX
Other stock markets
 03:04:46 2024-04-18 pm EDT 		5-day change 1st Jan Change
1.515 USD +1.00% Intraday chart for CEL-SCI Corporation -9.04% -44.49%
Feb. 14 CEL-SCI Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
Feb. 13 Cel-Sci Closes $7.8 Million Share Offering MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology
BU
CEL-SCI Corporation Issues Letter to Shareholders
BU
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results
BU
Cel-Sci: Fiscal Q1 Earnings Snapshot
AQ
CEL-SCI Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023
CI
Cel-Sci Closes $7.8 Million Share Offering
MT
CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock
BU
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock
AQ
Health Care Slips on Rotation to High-Risk Sectors -- Health Care Roundup
DJ
Cel-Sci Prices $7.8 Million Public Offering of Common Shares
MT
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock
BU
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head and Neck Cancer Drug
AQ
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug
BU
CEL-SCI Corporation Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug
CI
European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path towards Marketing Authorization for Multikine
AQ
Sector Update: Health Care Stocks Mixed Late Wednesday Afternoon
MT
Sector Update: Health Care Stocks Gain in Afternoon Trading
MT
Cel-Sci Receives Pediatric Requirements Waiver for Multikine From European Medicines Agency
MT
European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path Towards Marketing Authorization for Multikine®
BU
North American Morning Briefing : S&P 500 Futures Just Shy of Record High
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CVM Stock
  4. News CEL-SCI Corporation